serine has been researched along with npi 2358 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LoRusso, P; Mita, A; Mita, M; Spear, MA | 1 |
1 review(s) available for serine and npi 2358
| Article | Year |
|---|---|
Vascular disrupting agents (VDA) in oncology: advancing towards new therapeutic paradigms in the clinic.
Topics: Angiogenesis Inhibitors; Blood Vessels; Clinical Trials as Topic; Diketopiperazines; Humans; Neoplasms; Neovascularization, Pathologic; Serine; Tubulin | 2011 |